DeLorean Artificial Intelligence is a Miami, FL–based AI technology development company led by CEO and founder Dr. MacLaughlin. The company builds sentient and semi-sentient systems of intelligence designed to address business and economic challenges for Fortune 500 companies. Its core product, Medical AI, creates mathematical profiles of patient journeys and treatment methodologies to provide a predictive and proactive approach to treatment. Beyond Medical AI, DeLorean holds patent-pending rights to several proprietary AI capabilities including CPG Sales AI, a Ticket Analysis Prediction Engine (TAPE AI), and CRM AI. CRM AI, described as the company’s first patented product, can predict deal winnability and estimate financial impacts on revenue and costs, and works with any CRM platform while analyzing structured and unstructured data. The company says it will use new funds to accelerate adoption of Medical AI across the U.S., Europe, the Middle East, and Latin & South America; to date it has raised approximately $11M.

Total raised

$8M

Funding rounds

1

Latest round

Series A

Latest activity

Sep 2023